UHS · Universal Health Services Inc · Share Buybacks

$172.18 -5.14 (-2.90%) At close · Oct 28 Q2 2026 earnings call transcript

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$10.19B

58.94M

Volume · Oct 28 1.51M Avg daily vol (3M) 715.5K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized

$5,000,000,000

as of 2025-12-31 · total across 3 concurrent programs

Remaining Authorization

$1,400,000,000

as of 2025-12-31 · from 10-Q (reviewed)

Program Utilization

72.0% $3,600,000,000 used of $5,000,000,000

Program Announced	Authorized	Remaining	As of	Runs Through	Source
2025-10-27	—	$1,759,000,000	2025-10-27	—	8-K , filed 2025-10-28

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2026-06-30 YTD	$484,601,000	—	—	10-Q, filed 2026-08-07
2025-12-31	$967,951,000	—	—	10-K, filed 2026-02-25
2024-12-31	$670,754,000	—	—	10-K, filed 2026-02-25
2023-12-31	$547,363,000	—	—	10-K, filed 2026-02-25
2022-12-31	$832,918,000	—	—	10-K, filed 2025-02-26
2021-12-31	$1,220,875,000	—	—	10-K, filed 2024-02-27
2020-12-31	$206,719,000	—	—	10-K, filed 2023-02-27
2019-12-31	$770,504,000	—	—	10-K, filed 2022-02-24
2018-12-31	$397,425,000	—	—	10-K, filed 2021-02-25
2017-12-31	$364,401,000	—	—	10-K, filed 2020-02-26
2016-12-31	$353,380,000	—	—	10-K, filed 2019-02-27
2015-12-31	$209,782,000	—	—	10-K, filed 2018-02-28
2014-12-31	$100,749,000	—	—	10-K, filed 2017-02-28
2013-12-31	$27,201,000	—	—	10-K, filed 2016-02-25
2012-12-31	$19,154,000	—	—	10-K, filed 2015-02-26
2011-12-31	$60,482,000	—	—	10-K, filed 2014-02-27
2010-12-31	$11,528,000	—	—	10-K, filed 2013-02-28
2009-12-31	$63,288,000	—	—	10-K, filed 2012-02-27
2008-12-31	$149,404,000	—	—	10-K, filed 2011-02-28

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2026-06-30	$320,752,000 Δ	—	—	10-Q, filed 2026-08-07
2026-03-31	$163,849,000	—	—	10-Q, filed 2026-05-07
2025-12-31	$352,010,000 Δ	—	—	10-K, filed 2026-02-25
2025-09-30	$237,399,000 Δ	—	—	10-Q, filed 2025-11-07
2025-06-30	$155,157,000 Δ	—	—	10-Q, filed 2026-08-07
2025-03-31	$223,385,000	—	—	10-Q, filed 2026-05-07
2024-12-31	$250,166,000 Δ	—	—	10-K, filed 2026-02-25
2024-09-30	$182,601,000 Δ	—	—	10-Q, filed 2025-11-07
2024-06-30	$95,903,000 Δ	—	—	10-Q, filed 2025-08-08
2024-03-31	$142,084,000	—	—	10-Q, filed 2025-05-08
2023-12-31	$162,024,000 Δ	—	—	10-K, filed 2026-02-25
2023-09-30	$175,583,000 Δ	—	—	10-Q, filed 2024-11-08

Key facts CIK 352915 CUSIP 913903100 13F (30d) 161 filings 146 filers Visit website Investor relations